Molecule to Medicine Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
49
- Latest Deal Type
-
Later Stage VC
- Investors
-
1
Molecule to Medicine General Information
Description
Provider of biotechnology and pharmaceutical consulting services intended to design and manage drug discovery. The company's services offer operational and project assistance from the formation stage and guide the evolution of companies on the right trajectory with the translation of drug discovery activities, enabling small biotech companies to achieve the efficient discovery, development, and global commercialization of new human therapeutics.
Contact Information
Website
www.moleculetomedicine.comCorporate Office
- 99 Park Drive
- Abingdon OX14 4RY
- England, United Kingdom
Corporate Office
- 99 Park Drive
- Abingdon OX14 4RY
- England, United Kingdom
Molecule to Medicine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC | 01-May-2026 | Completed | Generating Revenue |
Molecule to Medicine Signals
Molecule to Medicine Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| UniQuest Extension Fund | Venture Capital | Minority |
Molecule to Medicine Investments (2)
Molecule to Medicine’s most recent deal was a Joint Venture with Lucia Bio. The deal was made on 01-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Lucia Bio | 01-Jan-2024 | Joint Venture | Drug Discovery | ||
| ThirtyFiveBio | 26-Jan-2021 | Joint Venture | Drug Discovery |
Molecule to Medicine FAQs
-
When was Molecule to Medicine founded?
Molecule to Medicine was founded in 2015.
-
Where is Molecule to Medicine headquartered?
Molecule to Medicine is headquartered in Abingdon, United Kingdom.
-
What is the size of Molecule to Medicine?
Molecule to Medicine has 49 total employees.
-
What industry is Molecule to Medicine in?
Molecule to Medicine’s primary industry is Consulting Services (B2B).
-
Is Molecule to Medicine a private or public company?
Molecule to Medicine is a Private company.
-
What is Molecule to Medicine’s current revenue?
The current revenue for Molecule to Medicine is .
-
Who are Molecule to Medicine’s investors?
UniQuest Extension Fund has invested in Molecule to Medicine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process